The Efficacy and Safety of Rifaximin Treatment

NCT05786859 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Liver Failure, Acute on Chronic
Hepatic Encephalopathy
HBV
Hepatitis B
Rifaximin
Effect of Drug

Interventions

DRUG: Rifaximin 200 mg
OTHER: Standard Treatment without Rifaximin

Sponsor

Sun Yat-sen University